Centric Wealth Management’s Amgen AMGN Stock Holding History

Centric Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,502	Closed	-$1.34M	–	117
2022 Q2	$1.34M	Buy	5,502 +196	+4%	+$48K	0.49%	58
2022 Q1	$1.28M	Buy	5,306 +287	+6%	+$65.9K	0.41%	72
2021 Q4	$1.13M	Buy	5,019 +488	+11%	+$103K	0.37%	70
2021 Q3	$963K	Buy	4,531 +112	+3%	+$25.8K	0.35%	68
2021 Q2	$1.08M	Buy	4,419 +119	+3%	+$29.3K	0.37%	66
2021 Q1	$1.07M	Sell	4,300 -17	-0.4%	-$4.06K	0.31%	89
2020 Q4	$993K	Buy	4,317 +1,597	+59%	+$368K	0.31%	88
2020 Q3	$515K	Sell	2,720 -514	-16%	-$127K	0.39%	62
2020 Q2	$763K	Buy	3,234 +514	+19%	+$117K	0.4%	64
2020 Q1	$515K	Sell	2,720 -178	-6%	-$38.9K	0.39%	62
2019 Q4	$699K	Buy	2,898 +178	+7%	+$39.2K	0.56%	45
2019 Q3	$515K	Buy	2,720 +145	+6%	+$27.8K	0.39%	62
2019 Q2	$474K	Buy	2,575 +6	+0.2%	+$1.07K	0.41%	62
2019 Q1	$488K	Buy	+2,569	New	+$491K	0.45%	57

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Centric Wealth Management's AMGN Position: Q3 2022 in Review

Centric Wealth Management sold out of Amgen (AMGN) in Q3 2022, closing a stake of 5,502 shares — an estimated $1.34M sold.

Centric Wealth Management first reported a position in AMGN in Q1 2019 and held it in 14 quarters. The position peaked at $1.34M in Q2 2022. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Centric Wealth Management reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Centric Wealth Management sold 5,502 Amgen shares in Q3 2022, an estimated $1.34M.
Centric Wealth Management first reported a position in Amgen in Q1 2019 and held it in 14 quarters.
Centric Wealth Management's Amgen position peaked at $1.34M in Q2 2022.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Centric Wealth Management's 13F filing for Q3 2022, filed 5 Oct 2022.